$GNTX

GENTEX CORP

No enriched coverage for $GNTX in the last 7 days.

No SEC Form 4 filings for $GNTX in the last 30 days.

See all $GNTX insider activity →
Med

Gentex Eyes $7B Revenue Path With Auto Tech, VOXX and Contract Manufacturing

Gentex (GNTX) aims for $4.5B-$7B revenue over 10 years, diversifying from auto mirrors to tech, VOXX, and manufacturing. It expects $2.5B revenue in 2025, with growth from Full Display Mirrors, driver-monitoring systems, and new products. VOXX acquisition exceeded targets, with improved margins and strategic value. Non-automotive revenue hit 14% in Q2. Gentex plans to expand contract manufacturing, targeting $1B-$2B revenue. The company returned $4.3B to shareholders over a decade and aims for $

US Auto Supplier Gentex to Open Manufacturing Plant in Morocco

Gentex said in its Q2 2026 earnings report it plans to open a manufacturing plant in Morocco, after signing a letter of intent, selecting a site, and receiving Moroccan government support. The facility would make electrochromic mirrors and electronic modules for European vehicle production, targeting start-up in 2028. Gentex reported Q2 2026 net sales of $651.3M and net income of $114.7M.

GNTX sentiment & insider activity

Recent GNTX coverage spans financial news and earnings.

What's driving GNTX

  • Guidance lift suggests higher future earnings and potential upside for the stock.

    yahoo.com · Aug 29, 2026

  • Hold rating at a low price level may attract value‑seeking buyers.

    theglobeandmail.com · Aug 21, 2026

  • Gentex said in its Q2 2026 earnings report it plans to open a manufacturing plant in Morocco, after signing a letter of intent, selecting a site, and receiving Moroccan government support. The facility would make electrochromic mirrors and electronic modules for European vehicle production, targeting start-up in 2028. Gentex reported Q2 2026 net sales of $651.3M and net income of $114.7M.

    moroccoworldnews.com · Jul 29, 2026

  • Results show margin improvement and diversification offsetting weaker automotive volumes, with tariff reimbursements cited as a key gross margin tailwind.

    finanznachrichten.de · Jul 24, 2026

  • Q2 results show margin expansion and record GAAP EPS despite slightly lower revenue, with tariff reimbursements and product mix as key drivers.

    SEC EDGAR 8-K · Jul 24, 2026

alphai scores every news story that mentions GNTX with an AI model for sentiment and relevance, and aggregates insider trades from GENTEX CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $GNTX

Score
$GNTXMedAI 8/10

Gentex Eyes $7B Revenue Path With Auto Tech, VOXX and Contract Manufacturing

Gentex (GNTX) aims for $4.5B-$7B revenue over 10 years, diversifying from auto mirrors to tech, VOXX, and manufacturing. It expects $2.5B revenue in 2025, with growth from Full Display Mirrors, driver-monitoring systems, and new products. VOXX acquisition exceeded targets, with improved margins and strategic value. Non-automotive revenue hit 14% in Q2. Gentex plans to expand contract manufacturing, targeting $1B-$2B revenue. The company returned $4.3B to shareholders over a decade and aims for $

US Auto Supplier Gentex to Open Manufacturing Plant in Morocco

Gentex said in its Q2 2026 earnings report it plans to open a manufacturing plant in Morocco, after signing a letter of intent, selecting a site, and receiving Moroccan government support. The facility would make electrochromic mirrors and electronic modules for European vehicle production, targeting start-up in 2028. Gentex reported Q2 2026 net sales of $651.3M and net income of $114.7M.

$GNTXMed

GENTEX CORP (GNTX): Results of Operations and Financial Condition

GENTEX CORP (GNTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99106302026.htm EX-99.1 Document Exhibit 99.1 GENTEX REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ZEELAND, MI -- (GLOBE NEWSWIRE - July 24, 2026) - Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire prote

$GNTXMed

Gentex (GNTX) director sells 5,939 Common Stock shares in market

Gentex Corp director Joseph B. Anderson Jr. sold 5,939 shares of Common Stock on May 15, 2026, at an average price of $22.9752 per share through an open-market transaction. This sale, valued at $136,450, resulted in his direct holding of Common Stock becoming 0 shares. The transaction was reported via a Form 4 filing, indicating a moderate impact and negative sentiment on the stock.

$GNTXMed

Gentex (GNTX) director Walker sells 5,939 shares, holds 24,205

Gentex Corp director Brian C. Walker reported an open-market sale of 5,939 shares of Gentex common stock at an average price of $22.9752 per share. Following this transaction, he retains a direct ownership of 24,205 Gentex shares. The filing indicates a "net-sell" direction with a moderate impact and negative sentiment, according to Rhea-AI.

$GNTXLow

Gentex Corp Stock (ISIN: US37253A1034) Holds Steady Amid Auto Sector Volatility as Q4 Earnings Loom

Gentex Corp's stock (ISIN: US37253A1034) is holding steady despite automotive market volatility, with investors keenly awaiting its Q4 earnings report. The company, a key supplier of automotive vision systems and ADAS technologies, is drawing attention from European investors due to its resilience and accessible trading on Xetra. Upcoming earnings are expected to shed light on demand for mirror tech and Full Display Mirror adoption, as the company navigates OEM relationships and sector trends.

$GNTXMed

P/E Ratio Insights for Gentex

Gentex (NASDAQ: GNTX) shares recently experienced a 0.13% spike, with its stock performing positively over the last month but decreasing over the past year. The article analyzes Gentex's P/E ratio of 14.01, which is lower than the Automobile Components industry average of 27.69, suggesting potential undervaluation but also caution regarding future growth or financial stability. Investors are advised to consider various financial metrics and qualitative factors in addition to the P/E ratio for comprehensive investment decisions.

Related tickers